Table 2.

Body weight changes by strain in chronically DOX-treated mice (total cumulative dose, 30 mg/kg)



Body weight, g
Treatment
Initial
Terminal
Wild-type   
Saline   20.8 ± 2.3   26.3 ± 4.0  
DOX    
Survivors   21.3 ± 0.8   25.2 ± 4.5  
Nonsurvivors   20.4 ± 2.2   18.4 ± 0.6* 
Hfe+/−   
Saline   20.3 ± 2.2   24.8 ± 2.0  
DOX    
Survivors   21.8 ± 2.4   22.2 ± 1.5* 
Nonsurvivors   21.3 ± 2.3   17.0 ± 1.3* 
Hfe−/−   
Saline   19.6 ± 1.9   24.3 ± 3.2  
DOX    
Survivors   19.9 ± 1.1   21.2 ± 1.9* 
Nonsurvivors
 
20.0 ± 1.4
 
17.8 ± 2.0*
 


Body weight, g
Treatment
Initial
Terminal
Wild-type   
Saline   20.8 ± 2.3   26.3 ± 4.0  
DOX    
Survivors   21.3 ± 0.8   25.2 ± 4.5  
Nonsurvivors   20.4 ± 2.2   18.4 ± 0.6* 
Hfe+/−   
Saline   20.3 ± 2.2   24.8 ± 2.0  
DOX    
Survivors   21.8 ± 2.4   22.2 ± 1.5* 
Nonsurvivors   21.3 ± 2.3   17.0 ± 1.3* 
Hfe−/−   
Saline   19.6 ± 1.9   24.3 ± 3.2  
DOX    
Survivors   19.9 ± 1.1   21.2 ± 1.9* 
Nonsurvivors
 
20.0 ± 1.4
 
17.8 ± 2.0*
 

Data are presented as means ± SD.

*

P < .05, comparison between saline-treated and DOX-treated mice.

P < .05, comparison between wild-type and mutant mice with the same treatment.

Close Modal

or Create an Account

Close Modal
Close Modal